Literature DB >> 17359362

Copper deficiency elicits glial and neuronal response typical of neurodegenerative disorders.

G G Zucconi1, S Cipriani, R Scattoni, I Balgkouranidou, D P Hawkins, K V Ragnarsdottir.   

Abstract

Dysregulation of copper homeostasis has been associated with neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis (ALS) and prion diseases. The investigation of the role of abnormal copper level in the development of neuropathological damage is essential for the understanding of pathogenetic mechanisms of these neurodegenerative disorders. Using a mouse model of perinatally induced copper deficiency, the present study analysed the response of neuronal and glial cells to copper deficiency from infancy to young adult age. In mice born and maintained after weaning on copper-deficient diet, copper measurements indicated that at 6-8 weeks the copper levels in the brain were decreased by about 80% with respect to controls. In the brain of copper-deficient mice, microglial and astrocytic activation was observed, mostly in the cerebral cortex and thalamus. In addition, small vacuolated globoid cells confined to the subgranular zone of the dentate gyrus were found in the third postnatal week, and larger vacuolar profiles, identified as neuronal vacuoles, were observed in layer V of the cortex after the fourth week. The spatial distribution and temporal onset of vacuolation appeared to be unrelated to those of activated microglia and astrocytes. Nitrotyrosine-positivity was found to reflect the distribution of vacuoles in the cortex. The specific histopathological features here reported, as well as the severity of neurological deficits observed in this murine model of copper deficiency, strongly suggest that some hallmarks of neurodegenerative disorders could be mediated by multifactorial pathogenetic mechanisms that include copper dysregulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359362     DOI: 10.1111/j.1365-2990.2006.00793.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  14 in total

Review 1.  Environmental and Dietary Exposure to Copper and Its Cellular Mechanisms Linking to Alzheimer's Disease.

Authors:  Heng-Wei Hsu; Stephen C Bondy; Masashi Kitazawa
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

2.  Fluorimetric analysis of copper transport mechanisms in the b104 neuroblastoma cell model: a contribution from cellular prion protein to copper supplying.

Authors:  Emanuela Urso; Antonia Rizzello; Raffaele Acierno; Maria Giulia Lionetto; Benedetto Salvato; Carlo Storelli; Michele Maffia
Journal:  J Membr Biol       Date:  2009-12-03       Impact factor: 1.843

3.  The Copper bis(thiosemicarbazone) Complex CuII(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu.

Authors:  Mikko T Huuskonen; Qing-Zhang Tuo; Sanna Loppi; Hiramani Dhungana; Paula Korhonen; Lachlan E McInnes; Paul S Donnelly; Alexandra Grubman; Sara Wojciechowski; Katarina Lejavova; Yuriy Pomeshchik; Laura Periviita; Lotta Kosonen; Martina Giordano; Frederick R Walker; Rong Liu; Ashley I Bush; Jari Koistinaho; Tarja Malm; Anthony R White; Peng Lei; Katja M Kanninen
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

4.  Effects of Axonal Demyelination, Inflammatory Cytokines and Divalent Cation Chelators on Thalamic HCN Channels and Oscillatory Bursting.

Authors:  Tengiz Oniani; Laura Vinnenberg; Rahul Chaudhary; Julian A Schreiber; Kathrin Riske; Brandon Williams; Hans-Christian Pape; John A White; Anna Junker; Guiscard Seebohm; Sven G Meuth; Petra Hundehege; Thomas Budde; Mehrnoush Zobeiri
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

Review 5.  Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.

Authors:  Tee Jong Huat; Judith Camats-Perna; Estella A Newcombe; Nicholas Valmas; Masashi Kitazawa; Rodrigo Medeiros
Journal:  J Mol Biol       Date:  2019-01-18       Impact factor: 5.469

Review 6.  The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health.

Authors:  Loren Pickart; Jessica Michelle Vasquez-Soltero; Anna Margolina
Journal:  Oxid Med Cell Longev       Date:  2012-05-10       Impact factor: 6.543

Review 7.  Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease.

Authors:  Marcus W Brazier; Anthony G Wedd; Steven J Collins
Journal:  Antioxidants (Basel)       Date:  2014-04-21

8.  The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline.

Authors:  Loren Pickart; Jessica Michelle Vasquez-Soltero; Anna Margolina
Journal:  Brain Sci       Date:  2017-02-15

9.  CuII(atsm) Attenuates Neuroinflammation.

Authors:  Xin Yi Choo; Jeffrey R Liddell; Mikko T Huuskonen; Alexandra Grubman; Diane Moujalled; Jessica Roberts; Kai Kysenius; Lauren Patten; Hazel Quek; Lotta E Oikari; Clare Duncan; Simon A James; Lachlan E McInnes; David J Hayne; Paul S Donnelly; Eveliina Pollari; Suvi Vähätalo; Katarína Lejavová; Mikko I Kettunen; Tarja Malm; Jari Koistinaho; Anthony R White; Katja M Kanninen
Journal:  Front Neurosci       Date:  2018-09-24       Impact factor: 4.677

Review 10.  Neuroinflammation and copper in Alzheimer's disease.

Authors:  Xin Yi Choo; Lobna Alukaidey; Anthony R White; Alexandra Grubman
Journal:  Int J Alzheimers Dis       Date:  2013-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.